Harnessing single-cell transcriptomics for the determination of sexual dimorphism during plasmodium falciparum gametocytogenesis

Active Project Grant Awarded Last action

Award ID
R21AI191113
Recipient
Awarding agency
Obligated
$196,625

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date 21% complete
Place of performance
State College, PA 16802, USA

Award details come from USAspending.gov.

About this award

The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Pennsylvania State University $196,625 on May 19, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct single-cell transcriptomics research on sexual dimorphism during Plasmodium falciparum gametocytogenesis.

The research applies single-cell RNA sequencing to uncover the molecular mechanisms governing sexual development and differentiation in the malaria parasite. The study leverages P. falciparum strains from geographically diverse sources and genetically engineered mutants in key gametocytogenesis regulators, using the 10X Genomics Chromium platform with Illumina short-read sequencing to map the temporal, single-cell transcriptional landscape of gametocytogenesis. The work addresses knowledge gaps in the timing and regulation of sex dimorphism, seeking to determine how sexual fate is specified following a branch point during the parasite's roughly 12-day transition from immature sexual stages to mature, differentiated male and female stages capable of transmission to the Anopheles mosquito vector.

Performance occurs in State College, Pennsylvania, with a period of performance through April 30, 2028. This is a Project Grant, an assistance type under the NIAID research program supporting biomedical research and research training in infectious diseases and related areas.

Description

Abstract
Unlike higher eukaryotes, unicellular organisms like the malaria parasite plasmodium falciparum rely on the precise regulation of molecular events that stabilize the development of one SEX lineage and/or repress the alternative fate. The development of p. Falciparum is closely tied to its complex life cycle where sexual differentiation within a subpopulation of host red blood cells is critical for transmission to the mosquito vector. This sexual lifecycle stage, known as gametocytogenesis is a lengthy process, taking approximately 12 days to transition from immature sexual stages (stage i) to mature, differentiated male and female stages (stage v) that can be taken up by the female anopheles mosquito. Despite extensive research efforts, the molecular mechanisms governing sexual development and dimorphism in p. Falciparum remain poorly understood. Recent studies have begun to shed light on sexual development using single-cell RNA sequencing (scrna-SEQ) and have defined a malaria cell atlas,. These studies suggest that sexual fate in malaria parasites is likely determined downstream of commitment, following a branch point during gametocytogenesis. However, significant knowledge gaps persist, particularly regarding the timing and regulation of SEX dimorphism. To address these gaps, we propose a comprehensive study leveraging scrna-SEQ to uncover the molecular mechanisms of cell fate determination using a combination of parasite genotypes from different geographical locations and unique genetic mutants in key regulators of gametocytogenesis. Our approach is structured around two specific aims. The first aim will determine the temporal, single-cell transcriptional landscape of gametocytogenesis using the 10X genomics chromium platform with short-read (illumina) sequencing using p. Falciparum strains from varying genetic backgrounds of africa, south america, and southeast asia origin. We will also refine the classification of gametocyte clusters associated with distinct stages (i-v) of gametocytogenesis and better delineate the earliest lineage bifurcations along the sexual trajectory. To accomplish this, we will measure and compare temporal, scrna-SEQ data from genetically modified strains with defects in known regulators of sexual-stage development. The second aim will capture the evolutionary dynamics of SEX-specific transcript isoform diversity. To assess the downstream impact of isoform regulators on gametocyte development, differentiation efficiency, morphology, and reproductive success, we will couple long-read (pacbio) sequencing to better elucidate masked transcriptional modules and differential exon usage during gametocytogenesis. Additionally, we will validate the role of candidate hub isoform regulator(s) using genetic manipulation techniques such as dicre-inducible conditional knockout (CKO). The outcomes of this proposal include identifying key regulators of sexual dimorphism and lineage-specific transcript isoforms used by malaria parasites to prepare for mosquito transmission.

Quick answers

Who received award R21AI191113?

R21AI191113 was awarded to The Pennsylvania State University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on May 19, 2026.

How much is award R21AI191113 worth?

$196,625 has been obligated on R21AI191113.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award